Lab-developed tests look likely to be removed from FDA oversight. That has to change, writes Walter G. Johnson.

Researchers optimized healthcare AI for diagnoses, analyzed gender bias in image searches and found tiny DNA circles that ...

Infection research stands at the forefront of global health initiatives, particularly considering emerging pathogens and antimicrobial resistance. The quest for effective interventions necessitates ...

Non-small cell lung cancer (NSCLC) remains a predominant cause of cancer-related mortality worldwide. In recent years, immune checkpoint inhibitors (ICIs) have emerged as a transformative therapeutic ...

Regeneron’s clinical trials are at the core of this mission. Regeneron is grateful to all clinical trial participants — ...

Phase 1: Discovery and Preclinical Phases: Identification and testing of potential drug compounds. Duration: 1 to 6 years.

Study confirms what cannabis users have long known - Study may lead to new treatment for sleep disorders like insomnia, ...

Objectives Secondary prevention of rheumatoid arthritis (RA) is generally considered potentially impactful because the entire ...

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revoluti ...

LifeSci Capital analyst Anshul Dhankher maintained a Buy rating on Perspective Therapeutics (CATX – Research Report ... The company has shown consistent execution in its clinical programs, ...

Additional member institutions will be announced and onboarded in subsequent phases. “The velocity of AI innovations ... we translate discovery into application and interconnect clinical care, ...